Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03277612 · ClinicalTrials.gov registry record
Effects of C-section Delivery on Infant Brain Development
A clinical trial, sponsored by Arkansas Children's Hospital Research Institute.
- Terminated
- Registry status
- 9
- Enrollment target
NCT03277612: Clinical Trial study, sponsored by Arkansas Children's Hospital Research Institute.
NCT03277612 is a clinical trial that was terminated before completion, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03277612 was terminated before completion, sponsored by Arkansas Children's Hospital Research Institute.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The study will help investigators learn more about whether different delivery modes influence infant's brain development
Primary Outcome
Evaluate the relationship between gut microbiome and brain structural in infants based on mode of delivery as determined by an MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2019-03-27 |
Why NCT03277612 stopped before completion
NCT03277612 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03277612 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03277612 about?
NCT03277612 is a clinical study titled "Effects of C-section Delivery on Infant Brain Development". The study will help investigators learn more about whether different delivery modes influence infant's brain development
What is the current status of trial NCT03277612?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2017-09-22. Estimated completion is 2019-03-27.
Who is sponsoring clinical trial NCT03277612?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI